
معرفی
Divya M Gupta, MD, serves as Assistant Professor in the Department of Medicine (Hematology and Oncology) at Northwestern University's Feinberg School of Medicine. She is actively engaged in clinical research and patient care with specialization in lung cancer therapeutics and molecular characterization.
Her academic foundation includes:
- BS from UC Berkeley (2012)
- MD from Case Western Reserve University School of Medicine (2017)
- Internal Medicine Residency at Stanford University (2020)
- Hematology/Oncology Fellowship at Stanford University (2023)
Dr. Gupta's research program centers on lung cancer pathophysiology and treatment optimization, with particular emphasis on NSCLC biomarker-driven therapies, molecular subtyping of neuroendocrine carcinomas, and health services research addressing cost barriers in cancer care. Her work bridges laboratory discoveries with clinical implementation through innovative trial designs and health policy analysis. Current investigations explore AI-driven care coordination, economic impacts of precision oncology, and novel combination therapies targeting EGFR-mutated tumors.
Analysis of her 2025 publications reveals a cohesive research trajectory focused on NSCLC across molecular, clinical, and health systems dimensions. Her work integrates genomic characterization with real-world treatment outcomes and patient-centered care delivery models, demonstrating strong translational impact from bench to bedside to population health.
Professional engagement includes:
- Member of International Association for the Study of Lung Cancer (IASLC) since 2023
- Member of American Society of Clinical Oncology (ASCO) since 2020
Dr. Gupta leads multiple clinical trials including NU FC19L02 (atezolizumab combinations for EGFR-mutant NSCLC), NU WU24L04 (ADI-PEG 20 combinations post-progression), DRUG PrE1702 (osimertinib comparative effectiveness), and PROSPECT LUNG (perioperative therapy optimization). Her trial portfolio demonstrates significant grant support through industry partnerships and institutional resources at the Robert H. Lurie Comprehensive Cancer Center.
Research activities are coordinated through Northwestern's Lurie Cancer Center, where she collaborates with multidisciplinary teams spanning medical oncology, pulmonology, pathology, and health services research to advance lung cancer therapeutics and care delivery models.

